Synaptogenix Inc.

NASDAQ: SNPX · Real-Time Price · USD
7.85
1.80 (29.86%)
At close: Jun 30, 2025, 3:59 PM

Synaptogenix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
5.58K 6.35K 5.71K 4.97K
Gross Profit
n/a -6.35K -5.71K -4.97K
Operating Income
-6.81M -8.31M -26.36M -12.62M
Interest Income
1.28M 1.65M 335.04K 7.11K
Pretax Income
-12.77M -6.04M -5.57M -12.61M
Net Income
-12.77M -6.04M -5.46M -12.6M
Selling & General & Admin
5.21M 6.34M 9.81M 8.28M
Research & Development
1.6M 1.97M 6.32M 4.34M
Other Expenses
n/a -0.00 n/a n/a
Operating Expenses
6.81M 8.31M 16.13M 12.62M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
-5,212B n/a n/a n/a
Cost & Expenses
n/a 8.31M 16.13M 12.62M
Income Tax Expense
-789.91B n/a -115.89K -7.11K
Shares Outstanding (Basic)
1.23M 466.08K 273K 200K
Shares Outstanding (Diluted)
1.23M 466.08K 279.57K 200.6K
EPS (Basic)
10.99M -29.56 -20.35 -62.87
EPS (Diluted)
10.99M -29.56 -20.35 -62.87
EBITDA
-12.76M -8.31M -16.13M -12.61M
EBIT
-12.77M -8.31M -16.13M -12.62M
Depreciation & Amortization
5.58K 6.35K 5.71K 4.97K